Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PACB | TMO | ISRG | EW | DXCM |
| Company | Pacific Biosciences | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.7200 | 580.17 | 385.55 | 87.63 | 128.14 |
| High | 1.9000 | 594.03 | 389.76 | 88.09 | 129.30 |
| Low | 1.6700 | 578.81 | 383.88 | 86.53 | 126.72 |
| Last | 1.7700 | 593.03 | 386.70 | 86.72 | 127.05 |
| Change | +0.0500 | +15.10 | +1.25 | -0.70 | -1.09 |
| % Change | +2.91% | +2.61% | +0.32% | -0.80% | -0.85% |
| Volume | 13,433,500 | 1,328,800 | 853,100 | 1,988,000 | 1,689,900 |
| 20-Day Average Volume | 15,310,615 | 1,520,875 | 1,409,655 | 2,873,645 | 2,780,495 |
| Previous Close | 1.7200 | 577.93 | 385.45 | 87.42 | 128.14 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6723 | 567.35 | 376.91 | 86.60 | 130.61 |
| 20-Day Raw Stochastic | 26.67% | 98.45% | 80.12% | 39.13% | 24.59% |
| 20-Day Relative Strength | 34.76% | 60.67% | 53.85% | 47.29% | 45.19% |
| Weighted Alpha | -80.58 | +17.24 | +29.65 | +3.61 | +9.57 |
| Today's Opinion | 88% Sell | 80% Buy | 72% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 72% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 96% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.28% since 05/03/24 | +3.61% since 05/03/24 | +1.40% since 05/03/24 | +1.72% since 05/03/24 | -1.03% since 05/03/24 |
| Low | 1.6600 on 05/08/24 | 565.34 on 05/07/24 | 380.13 on 05/08/24 | 84.81 on 05/06/24 | 126.72 on 05/10/24 |
| High | 2.1800 on 05/06/24 | 594.03 on 05/10/24 | 389.78 on 05/07/24 | 88.09 on 05/10/24 | 130.48 on 05/09/24 |
| 1-Month | |||||
| %Chg | -46.85% since 04/10/24 | +3.37% since 04/10/24 | -0.45% since 04/10/24 | -5.23% since 04/10/24 | -9.46% since 04/10/24 |
| Low | 1.2500 on 04/17/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 3.4700 on 04/11/24 | 594.03 on 05/10/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 141.25 on 04/11/24 |
| 3-Month | |||||
| %Chg | -73.34% since 02/09/24 | +7.68% since 02/09/24 | -0.39% since 02/09/24 | +2.01% since 02/09/24 | +5.46% since 02/09/24 |
| Low | 1.2500 on 04/17/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 113.05 on 02/28/24 |
| High | 6.8300 on 02/15/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | -72.85% since 11/10/23 | +32.25% since 11/10/23 | +39.36% since 11/10/23 | +35.06% since 11/10/23 | +35.09% since 11/10/23 |
| Low | 1.2500 on 04/17/24 | 439.11 on 11/13/23 | 281.12 on 11/13/23 | 64.07 on 11/13/23 | 94.55 on 11/13/23 |
| High | 10.6500 on 12/27/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 482,047 | 226,369,056 | 137,162,496 | 52,257,472 | 50,525,752 |
| Shares Outstanding, K | 272,343 | 381,716 | 354,700 | 602,600 | 397,684 |
| Annual Sales | 200,520,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -306,740,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 58,360,000 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 921,000,000 |
| Last Quarter Net Income | -82,020,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 146,400,000 |
| 60-Month Beta | 1.99 | 0.80 | 1.39 | 1.10 | 1.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 05/09/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.32 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.73 | 82.36 | 34.28 | 77.19 |